Update (4/18/2023): We disagree with the court’s recent ruling that would prevent this important case from moving forward in New York. We intend to appeal the court’s decision in New York and to continue with our related suit in the District of Oregon where this novel exception to antitrust liability has not been adopted.

PharmacyChecker's work is laudable and unquestionably lawful, but it has been attacked and disparaged, we allege, by a conspiracy among the defendants, which are largely backed by pharmaceutical interests.

This is a case about a company, PharmacyChecker.com, that, for 20 years, has provided information that helps consumers safely find affordable prescription medication to treat conditions such as high blood pressure, asthma, and diabetes.